Next-Generation Complement-Targeted Gene Therapies in Complement Mediated Diseases

Time: 11:40 am
day: Conference Day Two


  • Reviewing Kriya’s gene therapies that precisely target dysregulation and hyperactivity of the complement system
  • Detailing the advantages of using gene therapy to target Geographic Atrophy and other ocular diseases
  • Looking forward to the next steps for Kriya